Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of a complex regional advance care planning intervention to improve care consistency with care preferences: study protocol for a multi-center, cluster-randomized controlled trial focusing on nursing home residents (BEVOR trial).
Götze K, Bausewein C, Feddersen B, Fuchs A, Hot A, Hummers E, Icks A, Kirchner Ä, Kleinert E, Klosterhalfen S, Kolbe H, Laag S, Langner H, Lezius S, Meyer G, Montalbo J, Nauck F, Reisinger C, Rieder N, Schildmann J, Schunk M, Stanze H, Vogel C, Wegscheider K, Zapf A, Marckmann G, In der Schmitten J; BEVOR study group. Götze K, et al. Trials. 2022 Sep 12;23(1):770. doi: 10.1186/s13063-022-06576-3. Trials. 2022. PMID: 36096948 Free PMC article.
Advance Care Planning in Germany.
Götze K, Feddersen B, In der Schmitten J, Marckmann G. Götze K, et al. Z Evid Fortbild Qual Gesundhwes. 2023 Aug;180:127-132. doi: 10.1016/j.zefq.2023.05.005. Epub 2023 Jun 29. Z Evid Fortbild Qual Gesundhwes. 2023. PMID: 37393112
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.
Shahswar R, Gabdoulline R, Krueger K, Wichmann M, Götze KS, Braitsch K, Meggendorfer M, Schmalbrock L, Bullinger L, Modemann F, Fiedler W, Krauter J, Kaun S, Rotermund S, Voß A, Behrens YL, Bergmann AK, Koller E, Beutel G, Thol F, Heidel F, Heuser M. Shahswar R, et al. Among authors: gotze ks. Leukemia. 2025 Jan 8. doi: 10.1038/s41375-024-02501-6. Online ahead of print. Leukemia. 2025. PMID: 39779979
CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia.
Braitsch K, Lorenzini T, Hefter M, Koch K, Nickel K, Peeken JC, Götze KS, Weber W, Allmann A, D'Alessandria C, Brosch-Lenz J, Bassermann F, Rudelius M, Verbeek M, Eiber M, Herhaus P. Braitsch K, et al. Among authors: gotze ks. Theranostics. 2025 Jan 1;15(1):19-29. doi: 10.7150/thno.101215. eCollection 2025. Theranostics. 2025. PMID: 39744224 Free PMC article.
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.
Götze K, Vrillon A, Dumurgier J, Indart S, Sanchez-Ortiz M, Slimi H, Raynaud-Simon A, Cognat E, Martinet M, Zetterberg H, Blennow K, Hourrègue C, Bouaziz-Amar E, Paquet C, Lilamand M. Götze K, et al. Alzheimers Res Ther. 2024 Oct 19;16(1):231. doi: 10.1186/s13195-024-01593-7. Alzheimers Res Ther. 2024. PMID: 39427171 Free PMC article.
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.
Bresser H, Schmoor C, Grishina O, Pfeifer D, Thomas J, Rehman UU, Crysandt M, Jost E, Thol F, Heuser M, Götze KS, Schlenk RF, Salih HR, Schittenhelm MM, Heil G, Schwaenen C, Müller-Tidow C, Brugger W, Kündgen A, de Wit M, Giagounidis A, Scholl S, Neubauer A, Krauter J, Bug G, May AM, Wäsch R, Duyster J, Döhner K, Ganser A, Döhner H, Hackanson B, Becker H, Lübbert M. Bresser H, et al. Among authors: gotze ks. Eur J Haematol. 2025 Feb;114(2):231-237. doi: 10.1111/ejh.14304. Epub 2024 Oct 13. Eur J Haematol. 2025. PMID: 39400388 Free PMC article. Clinical Trial.
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin.
Rücker FG, Bullinger L, Cocciardi S, Skambraks S, Luck TJ, Weber D, Krzykalla J, Pozek E, Schneider I, Corbacioglu A, Gaidzik VI, Meid A, Aicher S, Stegelmann F, Schrade A, Theis F, Fiedler W, Salih HR, Wulf G, Salwender H, Schroeder T, Götze KS, Kühn MWM, Lübbert M, Schlenk RF, Benner A, Thol F, Heuser M, Ganser A, Döhner H, Döhner K. Rücker FG, et al. Among authors: gotze ks. Blood Adv. 2024 Dec 10;8(23):6067-6080. doi: 10.1182/bloodadvances.2024013758. Blood Adv. 2024. PMID: 39348668 Free PMC article.
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.
Mazzeo P, Ganster C, Wiedenhöft J, Shirneshan K, Rittscher K, Brzuszkiewicz EB, Steinemann D, Schieck M, Müller-Thomas C, Treiber H, Braulke F, Germing U, Sockel K, Balaian E, Schanz J, Platzbecker U, Götze KS, Haase D. Mazzeo P, et al. Among authors: gotze ks. Hemasphere. 2024 Sep 23;8(9):e70014. doi: 10.1002/hem3.70014. eCollection 2024 Sep. Hemasphere. 2024. PMID: 39315323 Free PMC article.
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response.
Braitsch K, Jeske SD, Stroh J, Hefter M, Platen L, Bachmann Q, Renders L, Protzer U, Götze KS, Herhaus P, Verbeek M, Spinner CD, Bassermann F, Högner M, Haller B, Schneider J, Heider M. Braitsch K, et al. Among authors: gotze ks. Vaccines (Basel). 2024 Aug 1;12(8):871. doi: 10.3390/vaccines12080871. Vaccines (Basel). 2024. PMID: 39203997 Free PMC article.
206 results